Effect of osmotic protection on nucleated cell killing by C5b-9: cell death is not affected by the prevention of cell swelling.
Formation of C5b-9 channels in the plasma membrane can lead to erythrocyte lysis or nucleated cell death. Lysis of erythrocytes by complement occurs as a result of colloid osmotic swelling and rupture of the plasma membrane, due to the unregulated flux of ions and water through C5b-9 channels. This colloid osmotic mechanism of lysis is largely based on the evidence that the extent of hemolysis is reduced, when macromolecules are placed in the medium to balance the osmotic gradient created by intracellular macromolecules, which are too large to diffuse through complement channels. The role of colloid osmotic deregulation, as a cause of nucleated cell killing by C5b-9, however, has been recently questioned [Kim S., Carney D. F. and Shin M. L. J. Immun. 138, 1530 (1987)]. In the present study, we investigated the effect of osmotic protection, with an 81,000 mol. wt dextran or bovine serum albumin, on Ehrlich cell killing by complement channels. The results indicated that prevention of cell swelling by dextran did not reduce the extent or rate of nucleated cell killing by either small (C5b-9l), or large (C5b-9m), complement channels when assessed by vital dye stain. The release of cytoplasmic lactate dehydrogenase as an alternative measure of cell death, however, was retarded and/or reduced, in the presence of dextran or albumin, at concns that prevented cell swelling. These results indicate that C5b-9 can kill nucleated cells effectively, in the absence of colloidal osmotic cell swelling, and that release of cytoplasmic macromolecules may not be a reliable indicator of cell death, when osmotic protectants are employed.
Kim
S H
SH
Department of Pathology, University of Maryland School of Medicine, Baltimore 21201.
Carney
D F
DF
Papadimitriou
J C
JC
Shin
M L
ML
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003185:Complement C8 / Q000502:physiology; D003186:Complement C9 / Q000502:physiology; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000502:physiology*; D003911:Dextrans / Q000494:pharmacology; D004912:Erythrocytes / Q000502:physiology; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009995:Osmosis; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000502:physiology
D003185:Complement C8; D003186:Complement C9; D015938:Complement Membrane Attack Complex; D003911:Dextrans; D012710:Serum Albumin, Bovine; D003165:Complement System Proteins; D007770:L-Lactate Dehydrogenase